These recent advances have changed the classification and introduced molecular subtypes of the AML with gene mutations (NPM1 and CEPBA) by the recommendation of WHO classification of hematopoietic tumors in 2008 (Campo et al., 2008). The gene discussed is NPM1; the disease is acute myeloid leukemia.